Otsuka Holdings Co., Ltd. stock is traded under the ticker #4578. Below you can review Otsuka Holdings Co., Ltd. stock performance in the past 12 months up to November 2025

Total visits to Otsuka Holdings Co., Ltd.'s top domains

Understand Otsuka Holdings Co., Ltd. market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

otsuka.com1.9M

otsuka.co.jp1.9M

hellobonafide.com312.7K

See more with Sales Intelligence

Avg. visit duration in Otsuka Holdings Co., Ltd.'s top domains

Analyze Otsuka Holdings Co., Ltd. engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

otsuka.com00:01:12

otsuka.co.jp00:01:12

hellobonafide.com00:01:01

See more with Sales Intelligence

Avg. pageviews on Otsuka Holdings Co., Ltd.'s top domains

See how Otsuka Holdings Co., Ltd. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

otsuka.com1.85

otsuka.co.jp1.85

hellobonafide.com2.52

See more with Sales Intelligence

Otsuka Holdings Co., Ltd. top competitors by domain

Top similar sites in November 2025, ranked by their affinity

chugai-pharm.co.jpCompany NameChugai Pharmaceutical Co., Ltd.Employees5001 - 10000HQJapan, Chūō-kuAnnual revenue> $1BTotal visits305.4KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Otsuka Holdings Co., Ltd.

These are the website technologies, by industry, used by Otsuka Holdings Co., Ltd. top domains

Payment & Currencies (24)

Cart Functionality

Marketing (3)

Google Marketing Platform

Advertising (2)

DoubleClick

Mobile (2)

Meta Viewport

More Technologies

2

See all

News & Signals from Otsuka Holdings Co., Ltd.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsOtsuka Pharmaceutical Co attends event 2025 American Society of Nephrology (ASN) annual Kidney Week.Otsuka Pharmaceutical, Co. Ltd. (Otsuka) announces that findings from a 12-month interim analysis of sibeprenlimab for the treatment of immunoglobulin A nephropathy (IgAN) in adults were presented in a late-breaking presentation session at the 2025 American Society of Nephrology (ASN) annual Kidney Week meeting in houston, texas.

NewsOtsuka Pharmaceutical Co attended event 2025 Transcatheter Cardiovascular Therapeutics (TCT) conference on Oct 30th '25.Oct. 30, 2025 - Recor Medical and its parent company, Otsuka Medical Devices presented the results from two clinical studies presented at the recent 2025 Transcatheter Cardiovascular Therapeutics (TCT) conference.

NewsHarbour Biomed partners with Otsuka Pharmaceutical Co.Harbour BioMed has entered a strategic partnership with Otsuka Pharmaceutical focusing on the development of HBM7020, a B-cell maturation antigen (BCMA) xcluster [cross cluster] of differentiation 3 (CD3) bispecific T-cell engager aimed at treating autoimmune diseases.